US2018221495A1PendingUtilityA1

Active principle for mitigating undesired medical conditions

50
Assignee: PVAC MEDICAL TECH LTDPriority: Jan 31, 2011Filed: Apr 3, 2018Published: Aug 9, 2018
Est. expiryJan 31, 2031(~4.5 yrs left)· nominal 20-yr term from priority
A61L 26/00A61K 31/785A61K 31/787A61K 47/32A61K 31/765A61P 29/00A61K 9/0014A61K 47/61A61K 47/58
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for treating or preventing the symptoms associated with hang over in an individual suffering from or being at risk for such conditions. The method includes the steps of: i) providing the composition of the invention containing AP, and ii) contacting AP with the mediator a) within the individual, or b) separate from the individual.

Claims

exact text as granted — not AI-modified
1 . A method for treating or preventing the symptoms associated with hang over in an individual suffering from or being at risk for suffering from such, the method comprising the steps of:
 i) providing a composition containing as an active principle (=AP) a carrier which exhibits a plurality of a scavenger structure which is capable blocking of alcohol metabolite acetaldehyde, wherein the scavenger comprises a nucleophilic center, and   ii) systematically administrating the AP;   wherein the carrier is a polyvinyl alcohol and the nucleophilic center is a hydrazide group.   
     
     
         2 . The method according to  claim 1 , wherein the numbers of nucleophilic centres per monomeric unit of the polyvinyl alcohol is 10 to 80%. 
     
     
         3 . The method according to  claim 1 , wherein the numbers of nucleophilic centres per monomeric unit of the polyvinyl alcohol is 12.7 to 50%. 
     
     
         4 . The method according to  claim 1 , wherein the hydriazide group is selected from the group consisting of: —NH—NH 2 , a semicarbazide group, a carbazate group, a thiosemicarbazide group, and a thiocarbazate group. 
     
     
         5 . The method according to  claim 4 , wherein the hydrozide group is carbazate. 
     
     
         6 . The method according to  claim 1 , wherein the numbers of monomeric units of the polyvinyl alcohol is 200-600. 
     
     
         7 . The method according to  claim 1 , wherein the composition is in the form of a solution, dispersion, syrup, tablet or capsules.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.